1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-obesity Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-obesity Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Peripherally Acting Anti-obesity Drugs
1.4.3 Centrally Acting Anti-obesity Drugs
1.5 Market by Application
1.5.1 Global Anti-obesity Drugs Market Share by Application: 2021-2026
1.5.2 Kids
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Anti-obesity Drugs Market
1.8.1 Global Anti-obesity Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Anti-obesity Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Anti-obesity Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-obesity Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Anti-obesity Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Anti-obesity Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Anti-obesity Drugs Sales Volume
3.3.1 North America Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Anti-obesity Drugs Sales Volume
3.4.1 East Asia Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Anti-obesity Drugs Sales Volume (2015-2020)
3.5.1 Europe Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Anti-obesity Drugs Sales Volume (2015-2020)
3.6.1 South Asia Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Anti-obesity Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Anti-obesity Drugs Sales Volume (2015-2020)
3.8.1 Middle East Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Anti-obesity Drugs Sales Volume (2015-2020)
3.9.1 Africa Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Anti-obesity Drugs Sales Volume (2015-2020)
3.10.1 Oceania Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Anti-obesity Drugs Sales Volume (2015-2020)
3.11.1 South America Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Anti-obesity Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Anti-obesity Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Anti-obesity Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Anti-obesity Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Anti-obesity Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Anti-obesity Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Anti-obesity Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Anti-obesity Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Anti-obesity Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Anti-obesity Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Anti-obesity Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Anti-obesity Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Anti-obesity Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Anti-obesity Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Anti-obesity Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Anti-obesity Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Anti-obesity Drugs Consumption Volume by Application (2015-2020)
15.2 Global Anti-obesity Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Anti-obesity Drugs Business
16.1 Merck
16.1.1 Merck Company Profile
16.1.2 Merck Anti-obesity Drugs Product Specification
16.1.3 Merck Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Vivus
16.2.1 Vivus Company Profile
16.2.2 Vivus Anti-obesity Drugs Product Specification
16.2.3 Vivus Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Arena Pharmaceuticals
16.3.1 Arena Pharmaceuticals Company Profile
16.3.2 Arena Pharmaceuticals Anti-obesity Drugs Product Specification
16.3.3 Arena Pharmaceuticals Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Novo Nordisk
16.4.1 Novo Nordisk Company Profile
16.4.2 Novo Nordisk Anti-obesity Drugs Product Specification
16.4.3 Novo Nordisk Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Orexigen Therapeutics
16.5.1 Orexigen Therapeutics Company Profile
16.5.2 Orexigen Therapeutics Anti-obesity Drugs Product Specification
16.5.3 Orexigen Therapeutics Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Pfizer
16.6.1 Pfizer Company Profile
16.6.2 Pfizer Anti-obesity Drugs Product Specification
16.6.3 Pfizer Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Alizyme
16.7.1 Alizyme Company Profile
16.7.2 Alizyme Anti-obesity Drugs Product Specification
16.7.3 Alizyme Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 GlaxoSmithKline
16.8.1 GlaxoSmithKline Company Profile
16.8.2 GlaxoSmithKline Anti-obesity Drugs Product Specification
16.8.3 GlaxoSmithKline Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Roche
16.9.1 Roche Company Profile
16.9.2 Roche Anti-obesity Drugs Product Specification
16.9.3 Roche Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Amylin
16.10.1 Amylin Company Profile
16.10.2 Amylin Anti-obesity Drugs Product Specification
16.10.3 Amylin Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Boehringer Ingelheim
16.11.1 Boehringer Ingelheim Company Profile
16.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Specification
16.11.3 Boehringer Ingelheim Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Eisai
16.12.1 Eisai Company Profile
16.12.2 Eisai Anti-obesity Drugs Product Specification
16.12.3 Eisai Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Anti-obesity Drugs Manufacturing Cost Analysis
17.1 Anti-obesity Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Anti-obesity Drugs
17.4 Anti-obesity Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Anti-obesity Drugs Distributors List
18.3 Anti-obesity Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Anti-obesity Drugs (2021-2026)
20.2 Global Forecasted Revenue of Anti-obesity Drugs (2021-2026)
20.3 Global Forecasted Price of Anti-obesity Drugs (2015-2026)
20.4 Global Forecasted Production of Anti-obesity Drugs by Region (2021-2026)
20.4.1 North America Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Anti-obesity Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Anti-obesity Drugs by Country
21.2 East Asia Market Forecasted Consumption of Anti-obesity Drugs by Country
21.3 Europe Market Forecasted Consumption of Anti-obesity Drugs by Countriy
21.4 South Asia Forecasted Consumption of Anti-obesity Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Anti-obesity Drugs by Country
21.6 Middle East Forecasted Consumption of Anti-obesity Drugs by Country
21.7 Africa Forecasted Consumption of Anti-obesity Drugs by Country
21.8 Oceania Forecasted Consumption of Anti-obesity Drugs by Country
21.9 South America Forecasted Consumption of Anti-obesity Drugs by Country
21.10 Rest of the world Forecasted Consumption of Anti-obesity Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer